» Articles » PMID: 38502885

Morusin Alleviates Aortic Valve Calcification by Inhibiting Valve Interstitial Cell Senescence Through Ccnd1/Trim25/Nrf2 Axis

Overview
Journal Adv Sci (Weinh)
Date 2024 Mar 19
PMID 38502885
Authors
Affiliations
Soon will be listed here.
Abstract

The senescence of aortic valve interstitial cells (VICs) plays a critical role in the progression of calcific aortic valve disease (CAVD). However, the precise mechanisms underlying the senescence of VICs remain unclear, demanding the identification of a novel target to mitigate this process. Previous studies have highlighted the anti-aging potential of morusin. Thus, this study aimed to explore the therapeutic potential of morusin in CAVD. Cellular experiments reveal that morusin effectively suppresses cellular senescence and cause a shift toward osteogenic differentiation of VICs in vitro. Mechanistically, morusin activate the Nrf2-mediated antiaging signaling pathway by downregulating CCND1 expression and aiding Keap1 degradation through Trim 25. This activation lead to the upregulated expression of antioxidant genes, thus reducing reactive oxygen species production and thereby preventing VIC osteogenic differentiation. In vivo experiments in ApoE mice on a high-fat Western diet demonstrate the positive effect of morusin in mitigating aortic valve calcification. These findings emphasize the antiaging properties of morusin and its potential as a therapeutic agent for CAVD.

Citing Articles

Analysis of cellular senescence-related genes in calcified aortic valve disease and the potential therapeutic role of β-Carotene.

Tao Y, Gao C, Wang J, Zhang Q, Wang Z, Han L PLoS One. 2025; 20(3):e0318574.

PMID: 40063555 PMC: 11892872. DOI: 10.1371/journal.pone.0318574.


Identification and validation of autophagy‑related genes in hypertrophic cardiomyopathy.

Qiu R, Zhao S, Li Z, Zeng R, Qiu Z, Peng H Exp Ther Med. 2024; 28(6):440.

PMID: 39355520 PMC: 11443588. DOI: 10.3892/etm.2024.12729.


FOXO1 regulates RUNX2 ubiquitination through SMURF2 in calcific aortic valve disease.

Jiang C, Yao D, Liu Z, Zheng Y, Chen M, Yim W Redox Biol. 2024; 73:103215.

PMID: 38810422 PMC: 11167395. DOI: 10.1016/j.redox.2024.103215.


Morusin Alleviates Aortic Valve Calcification by Inhibiting Valve Interstitial Cell Senescence Through Ccnd1/Trim25/Nrf2 Axis.

Liu Z, Wang K, Jiang C, Chen Y, Liu F, Xie M Adv Sci (Weinh). 2024; 11(20):e2307319.

PMID: 38502885 PMC: 11132047. DOI: 10.1002/advs.202307319.

References
1.
Yang C, Deng X, Wu L, Jiang T, Fu Z, Li J . Morusin Protected Ruminal Epithelial Cells against Lipopolysaccharide-Induced Inflammation through Inhibiting EGFR-AKT/NF-κB Signaling and Improving Barrier Functions. Int J Mol Sci. 2022; 23(22). PMC: 9695078. DOI: 10.3390/ijms232214428. View

2.
Osman L, Yacoub M, Latif N, Amrani M, Chester A . Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation. 2006; 114(1 Suppl):I547-52. DOI: 10.1161/CIRCULATIONAHA.105.001115. View

3.
Ulasov A, Rosenkranz A, Georgiev G, Sobolev A . Nrf2/Keap1/ARE signaling: Towards specific regulation. Life Sci. 2021; 291:120111. PMC: 8557391. DOI: 10.1016/j.lfs.2021.120111. View

4.
Aghagolzadeh P, Radpour R, Bachtler M, Goor H, Smith E, Lister A . Hydrogen sulfide attenuates calcification of vascular smooth muscle cells via KEAP1/NRF2/NQO1 activation. Atherosclerosis. 2017; 265:78-86. DOI: 10.1016/j.atherosclerosis.2017.08.012. View

5.
Yosef R, Pilpel N, Papismadov N, Gal H, Ovadya Y, Vadai E . p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling. EMBO J. 2017; 36(15):2280-2295. PMC: 5538795. DOI: 10.15252/embj.201695553. View